ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,811 | +6.3% | 115,454 | +1.3% | 0.03% | +13.0% |
| Q2 2023 | $10,170 | -25.4% | 113,952 | -10.4% | 0.02% | -30.3% |
| Q1 2023 | $13,629 | -10.9% | 127,116 | +1.5% | 0.03% | -17.5% |
| Q4 2022 | $15,290 | -99.9% | 125,198 | +1.8% | 0.04% | +14.3% |
| Q3 2022 | $12,694,000 | +0.4% | 122,928 | -9.6% | 0.04% | +2.9% |
| Q2 2022 | $12,640,000 | -26.3% | 135,979 | -7.0% | 0.03% | 0.0% |
| Q1 2022 | $17,162,000 | -14.7% | 146,231 | -2.2% | 0.03% | -12.8% |
| Q4 2021 | $20,120,000 | -18.2% | 149,557 | -3.1% | 0.04% | -22.0% |
| Q3 2021 | $24,604,000 | +4.1% | 154,359 | -14.1% | 0.05% | +4.2% |
| Q2 2021 | $23,626,000 | +10.5% | 179,603 | +8.2% | 0.05% | +2.1% |
| Q1 2021 | $21,389,000 | – | 165,961 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |